November 06, 2026
A Connecticut federal judge has granted final approval to a $29.6 million settlement between dozens of states and Glenmark Pharmaceuticals that resolves claims accusing the company of conspiring with competitors to drive up drug prices.
November 04, 2026
Dozens of state attorneys general urged a Connecticut federal judge Tuesday not to let Taro Pharmaceuticals block a swath of their price-fixing claims with a $200 million settlement it struck with plaintiffs in separate multidistrict litigation, arguing the claims and plaintiffs are too separate to bind one another.
October 30, 2026
A coalition of 48 states and territories is asking a Connecticut federal judge to give his final approval to a $29.6 million settlement with Glenmark Pharmaceuticals Ltd. that would end claims that the drugmaker conspired with competitors to inflate prices and allocate markets for generic drugs.
October 27, 2026
Law360 Healthcare Authority looks at a Novo Nordisk loss in its challenge to Eli Lilly's GLP-1 advertising, an Ohio verdict in wrongful death litigation over Johnson & Johnson's talc baby powder and other legal news from the past week.
October 26, 2026
A Connecticut federal judge carved a different path Friday for two later generic-drug price-fixing cases from state attorneys general, allowing Mylan executives to revoke their previous invocation of the Fifth Amendment unimpeded, after previously allowing the enforcers to challenge that revocation in the first case set for trial.
October 20, 2026
Law360 Healthcare Authority looks at the Second Circuit's denial of a drugmaker's request for full review of expert testimony for plaintiffs in a case alleging Tylenol causes autism, the preliminary approval of a $400 million settlement between Sandoz and a coalition of states in generic drug price-fixing litigation, and other legal news from the past week.
October 19, 2026
Mylan can use deposition testimony from one current and one former executive in next year's price-fixing trial, a Connecticut federal judge ruled Friday, but state attorneys general can bring up the company "pulling the strings" in the witnesses' decision to testify after originally invoking the Fifth Amendment.
October 16, 2026
A Connecticut federal judge granted preliminary approval Friday to a $400 million settlement between a coalition of states, Sandoz Inc. and its subsidiary Fougera Pharmaceuticals Inc. over allegations of generic drug price-fixing and market allocation, setting aside $280 million as restitution.
October 09, 2026
Taro Pharmaceuticals USA asked a Connecticut federal judge to toss generic-drug price-fixing claims brought by a coalition of states on behalf of consumers that are duplicative of claims the consumers have already resolved through settlements in separate multidistrict litigation.
October 08, 2026
Ascend Laboratories, Mayne Pharma and Citron Pharma asked a Connecticut federal judge Thursday to sign off on a settlement with a coalition of states resolving claims the companies were involved in an illegal conspiracy to fix prices and suppress competition for generic drugs in the United States.